Navidea Biopharmaceuticals Inc $1.43

up +0.15


29/8/2014 04:01 PM  |  AMEX : NAVB  
Industries : Health Services / Medical Appliances & Equipment
Get Trend Analysis Icon Get NAVB Trend Analysis - it has underperformed the S&P 500 by 74%

Partner Headlines

  1. Navidea Joins Essex Woodland's Rheumco, Will Develop Radiopharmaceuticals ...

    Benzinga
  2. UPDATE: Navidea Biopharma Announces Positive Lymphoseek Injection Results

    Benzinga
  3. Navidea Announces Presentation of Study Findings of Manocept Platform Imaging ...

    Benzinga
  4. UPDATE: Navidea Biopharma Offers Update on EMA Application For Lymphoseek, ...

    Benzinga
  5. Morning Gainers for Mar. 6, 2014: PXLW, SGMO, ERII, RGSE, NAVB, PSTI

    Benzinga
  6. Morning Movers for Mar. 5, 2014: FCEL, ARWR, SWHC, CPST Moving Higher

    Benzinga
  7. Navidea Announces EMA Continues Marketing Authorization Application Review ...

    Benzinga
  8. Stocks Hitting 52-Week Lows

    Benzinga
  9. US Stock Futures Up Ahead Of Jobless Claims

    Benzinga
  10. Navidea Biopharmaceuticals Announces Agreement with FDA on Special Protocol ...

    Benzinga
  11. Navidea to Collaborate with Maimonides Medical Center on Trial Utilizing ...

    Benzinga
  12. UPDATE: Aegis Capital Initiates Navidea Biopharmaceuticals at Hold

    Benzinga
  13. Navidea Biopharma Offers Interim Analysis Point of Phase 3 Head, Neck Cancer ...

    Benzinga
  14. Navidea Submits Lymphoseek Marketing Application in Europe

    Benzinga
  15. Navidea to Present Data from Lymphoseek Studies at RSNA, CTRC-AACR Meetings

    Benzinga
  16. Navidea Biopharma Says PDUFA Goal Date for Lymphoseek April 30, 2013

    Benzinga
  17. Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek Data ...

    Benzinga
  18. Morning Market Losers

    Benzinga
  19. Benzinga's Top Pre-Market Losers

    Benzinga
  20. Navidea Biopharmaceuticals Announces $50M Credit Facility with Platinum-Montaur ...

    Benzinga
  21. Biotechs With Upcoming PDUFA Dates

    Benzinga
  22. MModal, Unilever Among Stocks Up on High Volume Tuesday

    FoxBusiness
  23. Meta-analysis of Navidea Biopharmaceuticals Lymphoseek® Phase 3 Data Compared ...

    Benzinga
Trading Center